United States Diagnostic Standards (USDS) is a global medical science company providing independent, evidence-based analysis of the clinical value of medical products. Fueled by an expansive network of medical experts and scientists around the world, our technical and clinical assessments serve as a tool to drive, regulatory submissions, reimbursement decisions and market adoption. Our clients include some of the world’s leading pharmaceutical companies, clinical laboratories, diagnostic and medical device manufacturers.
USDS was established in 2009 by Jeff Cossman, M.D., President and Chairman, an internationally recognized leader in the field of molecular diagnostics and personalized medicine.
USDS is guided by a leadership team with extensive research, industry and academic experience to include: National Institute of Health, National Cancer Institute, CMS, FDA, Head of Pathology – Georgetown, PhRMA, AdvaMed and various other industry organizations.
Company’s Keywords:
biotechnology, life sciences
<0
<6000000
<2009